Iteos Shareholders Transition to Contingent Value Rights Following Concentra Acquisition
The acquisition of Iteos Therapeutics by Concentra Biosciences was formally completed on August 29, marking a significant corporate transition. Shareholders ...
© 2024 Stocks Today